Chase Hiller
Psychiatry · Saline, MINPI 1417525510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,336 and has fallen 57.6% since, to $566 in 2025.
Across 151 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$659
- Indivior Inc.$344
- Teva Pharmaceuticals USA, Inc.$293
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$263
- Neurocrine Biosciences, Inc.$233
- Lundbeck LLC$217
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,96498%
- Education$712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 33 | $659 |
| Indivior Inc. | 13 | $344 |
| Teva Pharmaceuticals USA, Inc. | 16 | $293 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $263 |
| Neurocrine Biosciences, Inc. | 10 | $233 |
| Lundbeck LLC | 12 | $217 |
| Johnson & Johnson | 10 | $211 |
| Alkermes, Inc. | 5 | $103 |
| Almatica Pharma LLC | 5 | $99 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $81 |
| E.r. Squibb & Sons, L.L.C. | 3 | $72 |
| Luye Pharma (USA) Ltd. | 2 | $44 |
| AbbVie | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 3 | $42 |
| Ironshore Pharmaceuticals Inc. | 2 | $40 |
| Tris Pharma Inc | 2 | $37 |
| Biogen | 2 | $35 |
| Corium, LLC | 2 | $33 |
| Novo Nordisk | 1 | $25 |
| CSL Behring | 1 | $20 |
| Merck | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Eisai Inc. | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $10 |
How this compares
$3,035 in reported general payments places this provider in the 85th percentile of 1,166 psychiatry providers in Michigan.
Other psychiatry in Saline
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
- Samuel WedesLivonia$158K
- Arash JavanbakhtDetroit$102K
- Theodore RuzaWest Bloomfield$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.